References
Ahmad R, Al-Mass A, Al-Ghawas D et al (2013) Interaction of osteopontin with IL-18 in obese individuals: implications for insulin resistance. PLoS ONE 8(5):e63944
Blackburn P, Després J-P, Lamarche B et al (2006) Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity 14(10):1747–1754
Blankenberg S, Luc G, Ducimetière P et al (2003) Interleukin-18 and the risk of coronary heart disease in European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 108(20):2453–2459
Bondia-Pons I, Ryan L, Martinez JA (2012) Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 68(4):701–711
Breyer MK, Rutten EPA, Vernooy JHJ, Spruit MA, Dentener MA, van der Kallen C, vanGreevenbroek MMJ, Wouters EFM (2011) Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med 105:1046–1053
Bruun J, Stallknecht B, Helge J, Richelsen B (2007) Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 157:465–471
Chen YC, Chen SD, Miao L, Liu ZG, Li W, Zhao ZX, Sun XJ, Jiang GX, Cheng Q (2012) Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis. J Neuroimmunol 243(1–2):56–60
Ching PL, Willett WC, Rimm EB et al (1996) Activity level and risk of overweight in male health professionals. Am J Public Health 86(1):25–30
Diehl S, Rincón M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39(9):531–536
Dinarello CA (1999) IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103(1):11–24
Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911–919
Gerdes N, Sukhova GK, Libby P et al (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195:245–257
Goyenechea E, Parra D, Martínez JA (2007) Impact of interleukin 6–174G > C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism 56(12):1643–1648
Gülçubuk A, Haktanir D, Cakiris A et al (2014) The effects of resveratrol on tissue injury, oxidative damage, and pro-inflammatory cytokines in an experimental model of acute pancreatitis. J Physiol Biochem 70(2):397–406
Gustafson B, Hammarstedt A, Andersson CX et al (2007) Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27(11):2276–2283
Helmersson J, Larsson A, Vessby B, Basu S (2005) Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 181(1):201–207
Hermsdorff H, Zulet MA, Abete I, Martínez JA (2011) A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr 50(1):61–69
Hermsdorff H, Zulet MA, Puchau B, Martínez JA (2011) Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34(3):161–170
Hermsdorff HH, Zulet MA, Martínez JA (2011) The implication of unknown bioactive compounds and cooking techniques in relations between the variety in fruit and vegetable intake and inflammation. Am J Clin Nutr 93(6):1384
Hermsdorff HHM, Puchau B, Bressan J, Martínez JA (2009) Association of retinol-binding protein-4 with dietary selenium intake and other lifestyle features in young healthy women. Nutrition 25(4):392–399
Hermsdorff HHM, Puchau B, Bressan J, Martínez JA (2010) Association of body Fat distribution with proinflammatory gene expression in peripheral blood mononuclear cells from young adult subjects. OMICS: J Integr Biol 14(3):297–307
Hung J, McQuillan BM, Chapman CML (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 25(6):1268–1273
Kim T, Choi S, Ha E et al (2013) IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol 50(2):189–200
Lavie CJ, Church TS, Milani RV, Earnest CP (2011) Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 31(3):137–145
Matthews DR, Hosker JP, Rudenski AS, Nayloret BA et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–9
McCarty MF (1999) Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, athanol and pentoxifylline. Med Hypotheses 52(5):465–477
Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454(7203):428–435
Moreno-Aliaga M, Campión J, Milagro FI et al (2005) Adiposity and proinflammatory state: the chicken or the egg. Adipocytes 1:1–16
Netea MG, Joosten LAB, Lewis E et al (2006) Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 12(6):650–656
Opstad TB, Pettersen AA, Arnesen H, Seljeflot I (2011) Circulating levels of IL-18 are significantly influenced by the IL-18 + 183 A/g polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol 10:110
Pannacciulli N, Cantatore FP, Minenna A et al (2001) C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International journal of obesity and related metabolic disorders. Int J Obes Relat Metab Disord 25(10):1416–1420
Pedersen M, Bruunsgaard H, Weis N et al (2003) Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 124(4):495–502
Petersen AMW, Pedersen BK (2006) The role of il-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 57(10):43–51
Quintero P, Milagro FI, Campion J, Martínez JA (2010) Impact of oxygen availability on body weight management. Med Hypotheses 74(5):901–907
Ropelle ER, Flores MB, Cintra DE et al (2010) IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKβ and ER stress inhibition. PLoS Biol 8(8):e1000465
Safavi SM, Ziaei R, Marac MR (2012) Association of serum ceruloplasmin level with obesity: some components of metabolic syndrome and high-sensitive C-reactive protein in Iran. J Obes 2012:951093
Simental-Mendía L, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304
Thaler JP, Schwartz MW (2010) Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 151(9):4109–4115
Vachharajani V, Granger DN (2009) Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life 61(4):424–430
Vasques ACJ, Novaes FS, de Oliveira MS et al (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93(3):e98–e100
Wang B, Li Q, Jiang Y et al (2011) Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese. Inflamm Res 60(1):63–68
Whitworth JA, Chalmers J (2004) World health organisation-international society of hypertension (WHO/ISH) hypertension guidelines. Clin Exp Hypertens 26(7–8):747–52
Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19(4):972–978
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148(2):209–214
Zilverschoon GRC, Tack CJ, Joosten LAB et al (2008) Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes 32(9):1407–1414
Zorrilla EP, Sanchez-Alavez M, Sugama S et al (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A 104(26):11097–11102
Zulet MA, Puchau B, Navarro C et al (2007) Biomarcadores del estado inflamatorio: nexo de unión con la obesidad y complicaciones asociadas. Nutr Hosp 22(5):511–527
Acknowledgments
We wish to thank the physician Blanca E. Martínez de Morentín, the nurse Salomé Pérez, and the technician Verónica Ciaurriz. This work was supported by Línea Especial about Nutrition, Obesity and Health (University of Navarra LE/97) and CIBERobn. We also thanks to Capes for a PhD scholarship awarded to JCC Carraro. J Bressan and HHM Hermsdorff are CNPq and FUNARBE-UFV fellows, respectively.
Conflict of interest
The authors declare that they have no competing interests.
Author contributions
JCCC analyzed and wrote the manuscript. HHMH contributed in the design, field work, data collection, and analysis. BP contributed in the design, field work, and data collection. MAZ, FIM, and JB contributed in the design and analysis. JAM contributed in the general coordination, design, and financial management. All authors assisted in editing the manuscript as well as reading and approving the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carraro, J.C.C., Hermsdorff, H.H.M., Puchau, B. et al. Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults. J Physiol Biochem 71, 527–535 (2015). https://doi.org/10.1007/s13105-015-0391-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-015-0391-2